
UAE-based ICBA becomes the first research center from the Arabian peninsula to deposit seeds in the Svalbard Global Seed Vault
Dubai, UAE – In an unprecedented journey across continents and time, Emirati seeds, collected and extensively studied at the International Center for Biosaline Agriculture (ICBA), have reached the Arctic, where they are now securely preserved in the world's most protected agricultural time capsule—the Svalbard Global Seed Vault.
This historic deposit, the first of its kind from the Gulf region, marks a pivotal step in safeguarding the future of agriculture and ensuring the long-term preservation of climate-resilient crops for generations to come.
For the first time, seeds from the UAE's pioneering agricultural research have been enshrined in the permafrost of Norway's Svalbard archipelago. This deposit includes 315 accessions belonging to 110 plant species, including Ghaf tree, the national tree of UAE, selected for their exceptional tolerance to drought, heat, and salinity—traits essential for agriculture in extreme environments. These seeds of 24 genera and 61 species, the result of ICBA's extensive research and conservation efforts, now stand alongside the world's most vital plant genetic resources.
Dr. Tarifa Alzaabi, Director General of ICBA, emphasized the far-reaching significance of this deposit, stating: "From the heart of the UAE to the Arctic permafrost, ICBA's seeds from UAE have embarked on a journey through time, ensuring future generations can access the genetic resources needed to sustain food production in a changing world. These seeds represent decades of research in plant breeding, biotechnology, and environmental adaptation. Many of these accessions have been carefully selected for their ability to thrive in extreme conditions, making them invaluable for global food security. By preserving them in the Svalbard Global Seed Vault, we are securing a vital agricultural legacy that will support innovation and resilience for years to come."
A Journey Through Time: UAE Seeds in the World's Agricultural Time Capsule
Nicknamed the "Doomsday Vault", the Svalbard Global Seed Vault is the ultimate safeguard for agricultural biodiversity. Located 1,300 kilometers from the North Pole, this facility is designed to protect seeds from conflict, natural disasters, climate change, and unforeseen global crises. With over 1.3 million seed samples from 6,200 plant species, it serves as the world's last-resort backup for crop diversity.
ICBA's deposit carries the agricultural DNA of the UAE and beyond—a genetic blueprint for future food security. From the sands of the Arabian Peninsula to the icy chambers of Svalbard, these seeds symbolize resilience, adaptation, and survival, encapsulating the UAE's vision for a sustainable, food-secure future.
For over two decades, ICBA has been a global leader in agricultural innovation, focusing on crops that flourish in arid and saline environments. The ICBA Genebank, home to over 17,000 accessions from 325 plant species, is among the world's most extensive collections of drought-, heat-, and salt-tolerant crops.
Preserving the Future: A Global Effort Rooted in the UAE's Vision
As global food systems face growing threats from climate change, desertification, and water scarcity, ICBA's contribution to the Svalbard Global Seed Vault reinforces the UAE's commitment to sustainability, innovation, and international collaboration. This deposit ensures that future scientists, farmers, and policymakers will have access to the seeds that hold the key to agricultural resilience.
From the UAE's arid landscapes to the frozen vaults of Svalbard, ICBA's seeds have been sealed away—not just as a safeguard for today, but as a promise for the future.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Dubai Eye
a day ago
- Dubai Eye
Abu Dhabi launches newborn genetic testing programme
Abu Dhabi has rolled out a newborn genetic screening programme for Emirati nationals across several hospitals, to enable early detection and diagnosis of genetic conditions. The Newborn Genetic Screening Programme offers whole genome sequencing to screen more than 815 treatable childhood genetic conditions, including metabolic disorders, immunodeficiencies, hematologic conditions, and rare diseases such as spinal muscular atrophy. Using genomics and artificial intelligence (AI), the first phase of the programme has been implemented as a voluntary option at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42. The initiative is planned to be expanded across all maternity hospitals to screen UAE nationals and children of Emirati mothers born in the emirate. By collecting and testing cord blood samples at birth, with parental consent, healthcare providers can identify conditions that may not be apparent at birth but could significantly affect a child's health if treatment is delayed. Results are reported within 21 days, and parents will receive genetic counselling and be referred to multidisciplinary specialists if any actionable findings are identified. 'Through early detection, personalised care and strategic foresight, we are building a future of healthier generations and reinforcing Abu Dhabi's position as a global leader in proactive, precision healthcare," said Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi. To support the rollout of the programme, DoH conducted a workshop to review the gene panel and patient journey with specialists from stakeholders across Abu Dhabi. DoH also collaborated with M42 to train 16 paediatricians and neonatologists across three maternity hospitals, Corniche Hospital, Danat Al Emarat and Kanad Hospital, on genetic counselling practices and the importance of newborn genetic screening. These initiatives aim to reduce the prevalence of genetic diseases, inform reproductive choices, facilitate access to early intervention, and empower families with vital health information, fostering a future where personalised, preventative healthcare is the standard. The Newborn Genetic Screening Programme is one of several initiatives that have been made possible by the Emirati Genome Programme, such as the Premarital Screening Programme, harnessing the power of genomics and latest technologies to promote informed decisions. These efforts pave the way forward for more precise and effective treatments, ensuring the long-term health and wellbeing of future generations of Emiratis.


TAG 91.1
a day ago
- TAG 91.1
Abu Dhabi launches newborn genetic testing programme
Abu Dhabi has rolled out a newborn genetic screening programme for Emirati nationals across several hospitals, to enable early detection and diagnosis of genetic conditions. The Newborn Genetic Screening Programme offers whole genome sequencing to screen more than 815 treatable childhood genetic conditions, making it one of the most comprehensive genetic screening programmes for newborns in the world. Using genomics and artificial intelligence (AI), the first phase of the programme has been implemented as a voluntary option at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42. The initiative is planned to be expanded across all maternity hospitals to screen UAE Nationals and children of Emirati mothers born in the emirate, further strengthening Abu Dhabi's leadership in preventive healthcare and precision medicine. By collecting and testing cord blood samples at birth, with parental consent, healthcare providers can identify conditions that may not be apparent at birth but could significantly affect a child's health if treatment is delayed. The conditions screened under the programme include metabolic disorders, immunodeficiencies, hematologic conditions, and rare diseases such as spinal muscular atrophy, which is treatable by gene therapy. Results are reported within 21 days, and parents will receive genetic counselling and be referred to multidisciplinary specialists if any actionable findings are identified. Her Excellency Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Healthcare begins long before symptoms appear, and today, empowered by science and technology, we can act earlier than ever before." Dr. Mohamed Al Ameri, Acting Director of Genome and Biobank Division, Department of Health – Abu Dhabi said: 'As we work to integrate genomics into our preventative healthcare infrastructure, we aim to expand this initiative to all maternity hospitals in the emirate, demonstrating how genomics can reshape healthcare, shifting from a one-size-fits-all model to a precise, proactive, and personalised approach that improves patient outcomes.' To support the rollout of the programme, DoH conducted a workshop to review the gene panel and patient journey with specialists from stakeholders across Abu Dhabi. DoH also collaborated with M42 to train 16 paediatricians and neonatologists across three maternity hospitals, Corniche Hospital, Danat Al Emarat and Kanad Hospital, on genetic counselling practices and the importance of newborn genetic screening. Early detection through this enhanced screening programme allows for timely medical intervention and aligns with Abu Dhabi's broader strategy to integrate genomics into various aspects of family health, including premarital screening and genetic counselling, thus creating a comprehensive, family-centred care ecosystem. These initiatives aim to reduce the prevalence of genetic diseases, inform reproductive choices, facilitate access to early intervention, and empower families with vital health information, fostering a future where personalised, preventative healthcare is the standard. The Newborn Genetic Screening Programme is one of several initiatives that have been made possible by the Emirati Genome Programme, such as the Premarital Screening Programme, harnessing the power of genomics and latest technologies to promote informed decisions. These efforts pave the way forward for more precise and effective treatments, ensuring the long-term health and wellbeing of future generations of Emiratis.


Al Etihad
a day ago
- Al Etihad
Department of Health – Abu Dhabi launches Newborn Genetic Screening Programme
18 Aug 2025 11:10 ABU DHABI (ALETIHAD)The Department of Health - Abu Dhabi (DoH), in alignment with the Emirati Genome Council's vision to realise a national shift towards personalised, precision healthcare, has launched the Newborn Genetic Screening Programme. The initiative translates Abu Dhabi's commitment to pioneering genomics-driven medicine that enables early detection and diagnosis, tailored interventions, and improved health outcomes for future Newborn Genetic Screening Programme offers whole genome sequencing to screen more than 815 treatable childhood genetic conditions, making it one of the most comprehensive genetic screening programmes for newborns the power of genomics and artificial intelligence (AI), the first phase of the programme has been implemented as a voluntary option at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42. The initiative is planned to be expanded across all maternity hospitals to screen UAE Nationals and children of Emirati mothers born in the emirate, further strengthening Abu Dhabi's leadership in preventive healthcare and precision collecting and testing cord blood samples at birth, with parental consent, healthcare providers can identify conditions that may not be apparent at birth but could significantly affect a child's health if treatment is delayed. The conditions screened under the programme include metabolic disorders, immunodeficiencies, hematologic conditions, and rare diseases such as spinal muscular atrophy, which is treatable by gene Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Healthcare begins long before symptoms appear, and today, empowered by science and technology, we can act earlier than ever added: 'This programme reflects Abu Dhabi's commitment to leveraging innovation to serve our community, starting from the first days of life. Through early detection, personalised care, and strategic foresight, we are building a future of healthier generations and reinforcing Abu Dhabi's position as a global leader in proactive, precision healthcare.'Dr. Mohamed Al Ameri, Acting Director of Genome and Biobank Division, Department of Health – Abu Dhabi said: 'As we work to integrate genomics into our preventative healthcare infrastructure, we aim to expand this initiative to all maternity hospitals in the emirate, demonstrating how genomics can reshape healthcare, shifting from a one-size-fits-all model to a precise, proactive, and personalised approach that improves patient outcomes.'To support the rollout of the programme, DoH conducted a workshop to review the gene panel and patient journey with specialists from stakeholders across Abu also collaborated with M42 to train 16 paediatricians and neonatologists across three maternity hospitals, Corniche Hospital, Danat Al Emarat and Kanad Hospital, on genetic counselling practices and the importance of newborn genetic comprehensive workshops were conducted for obstetricians, midwives, nurses and technical teams from these are reported within 21 days, and parents will receive genetic counselling and be referred to multidisciplinary specialists if any actionable findings are detection through this enhanced screening programme allows for timely medical intervention and aligns with Abu Dhabi's broader strategy to integrate genomics into various aspects of family health, including premarital screening and genetic counselling, thus creating a comprehensive, family-centred care ecosystem. These initiatives aim to reduce the prevalence of genetic diseases, inform reproductive choices, facilitate access to early intervention, and empower families with vital health information, fostering a future where personalised, preventative healthcare is the standard. The Newborn Genetic Screening Programme is one of several initiatives that have been made possible by the Emirati Genome Programme, such as the Premarital Screening Programme, harnessing the power of genomics and the latest technologies to promote informed decisions. These efforts pave the way forward for more precise and effective treatments, ensuring the long-term health and well-being of future generations of Emiratis. Source: Aletihad - Abu Dhabi